996 resultados para polystyrene-bound Schiff base
Resumo:
We demonstrate that the cccB gene, identified in the Bacillus subtilis genome sequence project, is the structural gene for a 10-kDa membrane-bound cytochrome c(551) lipoprotein described for the first time in B. subtilis. Apparently, CccB corresponds to cytochrome c(551) of the thermophilic bacterium Bacillus PS3. The heme domain of B. subtilis cytochrome c(551) is very similar to that of cytochrome c(550), a protein encoded by the cccA gene and anchored to the membrane by a single transmembrane polypeptide segment. Thus, B. subtilis contains two small, very similar, c-type cytochromes with different types of membrane anchors. The cccB gene is cotranscribed with the yvjA gene, and transcription is repressed by glucose. Mutants deleted for cccB or yvjA-cccB show no apparent growth, sporulation, or germination defect. YvjA is not required for the synthesis of cytochrome c(551), and its function remains unknown.
Resumo:
En aquest projecte s’han unificat les dades de l’empresa Solmania i s’han generat estadístiques i informes a diferents formats mitjançant una aplicació RIA implementada amb Adobe Flex. D’aquesta manera es pot fer un control dels paràmetres clau del negoci per ajudar a la companyia a aconseguir els objectius marcats d’una manera eficient. L’aplicatiu permet analitzar des de diversos punts de vista qualsevol tipus d’informació que genera el negoci i fer-ne comparatives de rendiment.
Resumo:
El beneficio principal de contar con una representación de la potencia causal (Cheng, 1997) es que ésta supone una descripción contexto-independiente de la influencia de una determinada causa sobre el efecto. Por lo tanto, una forma adecuada de poner a prueba la existencia de estos modelos mentales es crear situaciones en las que la gente observa o predice la efectividad de las causas diana en múltiples contextos. La naturaleza trans-situacional de la potencia trae consigo una serie de consecuencias testables que hemos puesto a prueba a lo largo de tres series experimentales. En la primera serie experimental investigamos la transferencia de la fuerza causal, aprendida en un contexto específico, a un contexto en el que la probabilidad o tasa base del efecto es diferente. Los participantes debían predecir la probabilidad del efecto dada la introducción de la causa en el nuevo contexto. En la segunda serie experimental estudiamos las estrategias utilizadas por las personas a la hora de descubrir relaciones causales. De acuerdo con el modelo de la potencia causal, si pretendemos descubrir la potencia de una causa, entonces lo más apropiado es introducirla en el contexto más informativo y menos ambiguo posible. En los distintos experimentos de la serie combinamos tanto contextos como causas probabilísticas y determinísticas. En la tercera serie experimental intentamos extender los hallazgos de Liljeholm & Cheng (2007), en los se encontró que la generalización entre contextos ocurre según las predicciones del modelo de potencia. Parece probable que el procedimiento de dos fases utilizado por los autores promueva la tendencia a ignorar algunos ensayos, generando artificialmente resultados consistentes con los esperados por la potencia. Además, cuando controlamos la P(E|C) independientemente de la potencia, el patrón de resultados se invirtió, contradiciendo lo esperado por el modelo de Cheng. En conclusión, existe cierta evidencia que apoya la existencia de modelos causales pero es necesario buscar formas adecuadas de poner a prueba estos modelos.
Resumo:
Rapid neurotransmitter release depends on the ability to arrest the SNAP receptor (SNARE)-dependent exocytosis pathway at an intermediate "cocked" state, from which fusion can be triggered by Ca(2+). It is not clear whether this state includes assembly of synaptobrevin (the vesicle membrane SNARE) to the syntaxin-SNAP-25 (target membrane SNAREs) acceptor complex or whether the reaction is arrested upstream of that step. In this study, by a combination of in vitro biophysical measurements and time-resolved exocytosis measurements in adrenal chromaffin cells, we find that mutations of the N-terminal interaction layers of the SNARE bundle inhibit assembly in vitro and vesicle priming in vivo without detectable changes in triggering speed or fusion pore properties. In contrast, mutations in the last C-terminal layer decrease triggering speed and fusion pore duration. Between the two domains, we identify a region exquisitely sensitive to mutation, possibly constituting a switch. Our data are consistent with a model in which the N terminus of the SNARE complex assembles during vesicle priming, followed by Ca(2+)-triggered C-terminal assembly and membrane fusion.
Resumo:
STAT transcription factors are expressed in many cell types and bind to similar sequences. However, different STAT gene knock-outs show very distinct phenotypes. To determine whether differences between the binding specificities of STAT proteins account for these effects, we compared the sequences bound by STAT1, STAT5A, STAT5B, and STAT6. One sequence set was selected from random oligonucleotides by recombinant STAT1, STAT5A, or STAT6. For another set including many weak binding sites, we quantified the relative affinities to STAT1, STAT5A, STAT5B, and STAT6. We compared the results to the binding sites in natural STAT target genes identified by others. The experiments confirmed the similar specificity of different STAT proteins. Detailed analysis indicated that STAT5A specificity is more similar to that of STAT6 than that of STAT1, as expected from the evolutionary relationships. The preference of STAT6 for sites in which the half-palindromes (TTC) are separated by four nucleotides (N(4)) was confirmed, but analysis of weak binding sites showed that STAT6 binds fairly well to N(3) sites. As previously reported, STAT1 and STAT5 prefer N(3) sites; however, STAT5A, but not STAT1, weakly binds N(4) sites. None of the STATs bound to half-palindromes. There were no specificity differences between STAT5A and STAT5B.
Resumo:
Human Fas ligand (L) (CD95L) and tumor necrosis factor (TNF)-alpha undergo metalloproteinase-mediated proteolytic processing in their extracellular domains resulting in the release of soluble trimeric ligands (soluble [s]FasL, sTNF-alpha) which, in the case of sFasL, is thought to be implicated in diseases such as hepatitis and AIDS. Here we show that the processing of sFasL occurs between Ser126 and Leu127. The apoptotic-inducing capacity of naturally processed sFasL was reduced by >1,000-fold compared with membrane-bound FasL, and injection of high doses of recombinant sFasL in mice did not induce liver failure. However, soluble FasL retained its capacity to interact with Fas, and restoration of its cytotoxic activity was achieved both in vitro and in vivo with the addition of cross-linking antibodies. Similarly, the marginal apoptotic activity of recombinant soluble TNF-related apoptosis-inducing ligand (sTRAIL), another member of the TNF ligand family, was greatly increased upon cross-linking. These results indicate that the mere trimerization of the Fas and TRAIL receptors may not be sufficient to trigger death signals. Thus, the observation that sFasL is less cytotoxic than membrane-bound FasL may explain why in certain types of cancer, systemic tissue damage is not detected, even though the levels of circulating sFasL are high.
Resumo:
An ab initio structure prediction approach adapted to the peptide-major histocompatibility complex (MHC) class I system is presented. Based on structure comparisons of a large set of peptide-MHC class I complexes, a molecular dynamics protocol is proposed using simulated annealing (SA) cycles to sample the conformational space of the peptide in its fixed MHC environment. A set of 14 peptide-human leukocyte antigen (HLA) A0201 and 27 peptide-non-HLA A0201 complexes for which X-ray structures are available is used to test the accuracy of the prediction method. For each complex, 1000 peptide conformers are obtained from the SA sampling. A graph theory clustering algorithm based on heavy atom root-mean-square deviation (RMSD) values is applied to the sampled conformers. The clusters are ranked using cluster size, mean effective or conformational free energies, with solvation free energies computed using Generalized Born MV 2 (GB-MV2) and Poisson-Boltzmann (PB) continuum models. The final conformation is chosen as the center of the best-ranked cluster. With conformational free energies, the overall prediction success is 83% using a 1.00 Angstroms crystal RMSD criterion for main-chain atoms, and 76% using a 1.50 Angstroms RMSD criterion for heavy atoms. The prediction success is even higher for the set of 14 peptide-HLA A0201 complexes: 100% of the peptides have main-chain RMSD values < or =1.00 Angstroms and 93% of the peptides have heavy atom RMSD values < or =1.50 Angstroms. This structure prediction method can be applied to complexes of natural or modified antigenic peptides in their MHC environment with the aim to perform rational structure-based optimizations of tumor vaccines.
Resumo:
CEA as well as normal cross-reacting antigens (NCA) are fixed to the cell membrane via phosphatidylinositol (PI). To find out whether these antigens are internalized after antibody contact, acid pH desorption was compared to phospholipase C (PLC)-mediated cleavage of the antigen anchor. With the former procedure, marked differences in the desorbability of individual MAbs were noted, while PLC was able to cleave off surface-bound immune complexes irrespective of the MAb involved. From this it is concluded that internalization of MAb complexes of CEA/NCA, if occurring at all, is a low efficiency process.
Resumo:
"Vegeu el resum a l'inici del document del fitxer adjunt"
Resumo:
Les escales de valoració al pacient politraumàtic són essencials per al seu maneig i pronòstic. Podem definir índexs de gravetat o probabilitat de supervivència. Segons quins paràmetres analitzi, podem parlar d’escales fisiològiques, anatòmiques, bioquímiques i els índexs de probabilitat de supervivència. El BISS és un model de probabilitat provat a Holanda que ha demostrat ser objectiu. El nostre treball consisteix en la validació del BISS als nostres pacients. Durant dos anys vàrem recollir 354 pacients podent incloure només 167 al nostre estudi. Els resultats van ser significatius amb l’estudi posterior, però degut a la gran pèrdua de pacients no podem afirmar la nostra hipòtesi.